DPP4 and Hypoglycemia: It increases the physiological concentration of glucagon like peptide GLP-1 and glucose dependent insulinotropic polypeptide (GIP) in body by inhibiting the enzyme dipeptidyl peptidase –IV (DPP-4) with well tolerated profile, no risk of weight gain and hypoglycemia.